Global Market for At-Home and Home Collection In Vitro Diagnostic (IVD) Testing, 2025–2030

The convenience revolution in healthcare has arrived—and diagnostics are at the center of it. The Global Market for At-Home and Home Collection In Vitro Diagnostic (IVD) Testing, 2025–2030 provides a comprehensive analysis of one of the fastest-evolving sectors of the diagnostics industry. Covering both self-administered over-the-counter (OTC) tests and home collection kits analyzed in central laboratories, this Kalorama Information report examines the technologies, market forces, and consumer behaviors transforming how patients engage with testing and care.

For diagnostic developers, investors, and healthcare strategists, The Global Market for At-Home and Home Collection In Vitro Diagnostic (IVD) Testing, 2025–2030 provides the essential insight needed to understand how home diagnostics are moving beyond niche applications to become a core component of modern healthcare delivery—and a key driver of the global IVD market’s future growth.

Building on the momentum sparked by the COVID-19 pandemic, the report explores how growing public confidence in self-testing is reshaping the landscape of infectious disease detection, chronic disease management, oncology, genetic testing, and wellness screening. While glucose monitoring and pregnancy testing continue to anchor the category, innovations in non-invasive sampling methods—from saliva and urine to breath analysis—are enabling a broader range of tests to move from clinic to home.

The global Home IVD testing market is segmented into several broad areas, including:

• Genetic
• Glucose/ HbA1c
• Infectious disease
• Other areas
• Pregnancy and Fertility
• Coagulation
• Fecal Occult Blood
• Cholesterol
• Drugs of Abuse

Each market segment includes a detailed analysis of regulatory trends, clinical practices, and recent product approvals, along with 2025 sales data and forecasts through 2030 across major world regions, including the United States, EMEA, Asia Pacific, and the Rest of World. The study profiles key market leaders and emerging competitors, evaluating how technological advances, consumer acceptance, and cost considerations will drive growth and shape competition.

The report also distinguishes between the two major segments:

• At-Home IVD Tests – fully self-administered tests providing immediate results (e.g., pregnancy and glucose monitoring).
• Home Collection IVD Tests – tests where patients collect samples and send them to a laboratory for analysis (e.g., fecal occult blood, genetic, and infectious disease testing).

Scope and Methodology

Using a combination of primary interviews and secondary research, the report delivers reliable market sizing, competitive intelligence, and growth projections based on 2025 as the base year. Forecasts through 2030 include compound annual growth rates (CAGRs) and regional performance indicators.

Despite the growing demand, the report also acknowledges ongoing challenges in cost-benefit analysis, reimbursement models, and regulatory and privacy frameworks that may shape the pace of adoption.

Please Note: Single user allows for up to 3 users for this report. Show more